Literature DB >> 24855080

Sepsis-related hypertensive response: friend or foe?

Mohamed Saleh1.   

Abstract

In daily practice acute arterial hypertension may occur during acute sepsis. No management guidelines concerning this issue figured in the latest sepsis campaign guidelines. Arterial hypertension occurring during sepsis could be an overlooked condition despite its potential haemodynamic harmful consequences. In this paper, a clinical study of acute hypertensive response related to sepsis is detailed. It shows that arterial hypertension, renal salt wasting and glomerular hyperfiltration can occur simultaneously during sepsis. Mechanisms and management options of sepsis-related arterial hypertensive response are also discussed. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24855080      PMCID: PMC4039975          DOI: 10.1136/bcr-2014-204610

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Glomerular hyperfiltration and albuminuria in critically ill patients.

Authors:  O Fuster-Lluch; M Gerónimo-Pardo; R Peyró-García; M Lizán-García
Journal:  Anaesth Intensive Care       Date:  2008-09       Impact factor: 1.669

2.  Long-term mortality and quality of life after septic shock: a follow-up observational study.

Authors:  Nicolas Nesseler; Anne Defontaine; Yoann Launey; Jeff Morcet; Yannick Mallédant; Philippe Seguin
Journal:  Intensive Care Med       Date:  2013-01-29       Impact factor: 17.440

3.  Hypertension in the immediate postoperative period.

Authors:  T J Gal; L H Cooperman
Journal:  Br J Anaesth       Date:  1975-01       Impact factor: 9.166

4.  Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial.

Authors:  Tim C Jansen; Jasper van Bommel; F Jeanette Schoonderbeek; Steven J Sleeswijk Visser; Johan M van der Klooster; Alex P Lima; Sten P Willemsen; Jan Bakker
Journal:  Am J Respir Crit Care Med       Date:  2010-05-12       Impact factor: 21.405

5.  Postoperative hypertension: a multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside.

Authors:  N A Halpern; M Goldberg; C Neely; R N Sladen; J S Goldberg; J Floyd; G Gabrielson; R J Greenstein
Journal:  Crit Care Med       Date:  1992-12       Impact factor: 7.598

6.  The neuropathology of septic shock.

Authors:  Tarek Sharshar; Djillali Annane; Geoffroy Lorin de la Grandmaison; Jean Philippe Brouland; Nicholas S Hopkinson; Gray Françoise
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

7.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

8.  Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial.

Authors:  Martin W Dünser; Esko Ruokonen; Ville Pettilä; Hanno Ulmer; Christian Torgersen; Christian A Schmittinger; Stephan Jakob; Jukka Takala
Journal:  Crit Care       Date:  2009-11-16       Impact factor: 9.097

9.  Impaired cerebrovascular autoregulation in patients with severe sepsis and sepsis-associated delirium.

Authors:  Patrick Schramm; Klaus Ulrich Klein; Lena Falkenberg; Manfred Berres; Dorothea Closhen; Konrad J Werhahn; Matthias David; Christian Werner; Kristin Engelhard
Journal:  Crit Care       Date:  2012-10-04       Impact factor: 9.097

10.  Increasing mean arterial blood pressure in sepsis: effects on fluid balance, vasopressor load and renal function.

Authors:  Thiago Domingos Corrêa; Madhusudanarao Vuda; Jukka Takala; Siamak Djafarzadeh; Eliézer Silva; Stephan Mathias Jakob
Journal:  Crit Care       Date:  2013-01-30       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.